当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:164.07亿  总市值:223.71亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金39,821,987,410.3125,805,029,245.7711,993,189,120.8654,627,677,371.07
  收到的税费返还588,977.41588,977.41575,688.96394,942.14
  收到其他与经营活动有关的现金368,254,545.51296,098,385.5114,925,050.64720,290,246.78
  经营活动现金流入小计40,190,830,933.2326,101,716,608.6812,108,689,860.4655,348,362,559.99
  购买商品、接受劳务支付的现金39,468,754,090.5326,061,155,569.1613,202,038,549.7649,548,843,506.34
  支付给职工以及为职工支付的现金626,161,020.19425,224,768.79243,185,245.23834,748,235.09
  支付的各项税费1,128,095,920.77803,866,224.99401,871,352.891,479,571,642.98
  支付其他与经营活动有关的现金1,018,252,683.85321,904,882.54154,770,431.481,826,079,651.76
  经营活动现金流出小计42,241,263,715.3427,612,151,445.4814,001,865,579.3653,689,243,036.17
  经营活动产生的现金流量净额-2,050,432,782.11-1,510,434,836.8-1,893,175,718.91,659,119,523.82
二、投资活动产生的现金流量:
  收回投资收到的现金3,139,870.643,139,870.643,139,870.6422,922,454.72
  取得投资收益收到的现金29,327,149.229,327,149.2-23,752,710.76
  处置固定资产、无形资产和其他长期资产收回的现金净额78,328.6335,28035,080387,130
  投资活动现金流入小计32,545,348.4732,502,299.843,174,950.6447,062,295.48
  购建固定资产、无形资产和其他长期资产支付的现金40,419,863.9420,579,477.27,353,156.13130,772,379.16
  支付其他与投资活动有关的现金---2,500,000,000
  投资活动现金流出小计40,419,863.9420,579,477.27,353,156.132,630,772,379.16
  投资活动产生的现金流量净额-7,874,515.4711,922,822.64-4,178,205.49-2,583,710,083.68
三、筹资活动产生的现金流量:
  取得借款收到的现金319,447,721.2160,000,000100,000,000315,981,517.06
  筹资活动现金流入小计319,447,721.2160,000,000100,000,000315,981,517.06
  偿还债务支付的现金636,348,932.49435,834,964.5168,409,692.671,033,278,332.44
  分配股利、利润或偿付利息支付的现金644,787,849.53618,447,171.448,763,561.7745,851,590.69
  其中:子公司支付给少数股东的股利、利润24,433,001.583,920,214.07-63,420,628.99
  支付其他与筹资活动有关的现金114,391,693.1877,442,297.7149,359,766.2119,185,020.28
  筹资活动现金流出小计1,395,528,475.21,131,724,433.65226,533,020.571,898,314,943.41
  筹资活动产生的现金流量净额-1,076,080,754-971,724,433.65-126,533,020.57-1,582,333,426.35
五、现金及现金等价物净增加额-3,134,388,051.58-2,470,236,447.81-2,023,886,944.96-2,506,923,986.21
  加:期初现金及现金等价物余额8,291,394,056.968,291,394,056.968,291,394,056.9610,798,318,043.17
  期末现金及现金等价物余额5,157,006,005.385,821,157,609.156,267,507,1128,291,394,056.96
补充资料:
  净利润-991,483,406.86-2,129,780,565.04
  资产减值准备-8,207,322.15-1,066,320.03
  固定资产和投资性房地产折旧-35,900,835.86-71,391,097.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,900,835.86-71,391,097.9
  无形资产摊销-27,273,148.39-47,240,380.75
  长期待摊费用摊销-5,648,711.51-9,527,114.56
  处置固定资产、无形资产和其他长期资产的损失--548.56-186,992.44
  固定资产报废损失-102,830.57-3,777.24
  公允价值变动损失---18,201,818.94
  财务费用-14,966,586.59-33,655,840.77
  投资损失--293,601,361.38--550,281,293.66
  递延所得税--16,264,245.5--27,785,122.48
  其中:递延所得税资产减少--12,065,726.92--25,194,866.71
    递延所得税负债增加--4,198,518.58--2,590,255.77
  存货的减少--349,381,141.6--993,860,192.72
  经营性应收项目的减少--2,066,194,870.11--442,419,289.56
  经营性应付项目的增加-17,549,011.2-1,217,684,408.04
  其他-2,888,532.64--
  现金的期末余额-5,821,157,609.15-8,291,394,056.96
  减:现金的期初余额-8,291,394,056.96-10,798,318,043.17
  现金及现金等价物的净增加额--2,470,236,447.81--2,506,923,986.21
公告日期2025-10-222025-08-212025-04-252025-03-20
审计意见(境内)标准无保留意见
TOP↑